Lv1
40 积分 2024-07-10 加入
Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?
1天前
待确认
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
23天前
已完结
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
2个月前
已完结
Targeting IFNβ in dermatomyositis
2个月前
已完结
Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study
2个月前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma The FUMANBA-1 Nonrandomized Clinical Trial
2个月前
已完结
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study
4个月前
已完结
Top advances of the year: Small cell lung cancer
4个月前
已完结
Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritis
5个月前
已完结
B-cell depletion in autoimmune diseases
6个月前
已完结
皖公网安备34019202002308
